Eotaxin, but not IL-8, is increased in upper and lower airways of allergic rhinitis subjects after nasal allergen challenge

Allergy and Asthma Proceedings

Volumn 32, Issue 3, 2011, Pages 230-238

  Semik Orzech, Aleksandra ^a   Barczyk, Adam ^a   Wiaderkiewicz, Ryszard ^a   Pierzchała, Władysław ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; INTERLEUKIN 8; PLACEBO; POLLEN ANTIGEN;

ADULT; ALLERGIC RHINITIS; ARTICLE; CELL COUNT; CELL LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; LEUKOCYTE DIFFERENTIAL COUNT; LOWER RESPIRATORY TRACT; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NASAL LAVAGE; NOSE MUCOSA; NOSE PROVOCATION TEST; PROTEIN SECRETION; PROVOCATION TEST; SPUTUM ANALYSIS; SPUTUM LEVEL; UPPER RESPIRATORY TRACT;

ADOLESCENT; ADULT; ALLERGENS; CELL COUNT; CHEMOKINE CCL11; EOSINOPHILS; HUMANS; INTERLEUKIN-8; MACROPHAGES; MALE; NASAL MUCOSA; NASAL PROVOCATION TESTS; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SPUTUM;

EID: 79956306400     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2011.32.3435     Document Type: Article

References (43)

1. Bousquet J, Van Cauwenberge P, and Khaltaev N. Aria Workshop Group; World Health Organization: Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108:147-334, 2001.
2. Ciprandi G, and Cirillo I. The lower airway pathology of rhinitis. J Allergy Clin Immunol 118:1105-1109, 2006. (Pubitemid 44666971)
3. Braunstahl GJ, and Hellings PW. Nasobronchial interaction mechanisms in allergic airways disease. Curr Opin Otolaryngol Head Neck Surg 14:176-182, 2006. (Pubitemid 43854377)
4. Meltzer EO, Szwarcberg J, and Pill MW. Allergic rhinitis, asthma, and rhinosinusitis: Diseases of the integrated airway. J Manag Care Pharm 10:310-317, 2004.
5. Braunstahl GJ, Overbeek SE, Kleinjan A, et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 107:469-476, 2001. (Pubitemid 32210027)
6. Beeh KM, Beier J, Kornmann O, et al. A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal allergic rhinitis: Correlation with plasma interleukin-5. Clin Exp Allergy 33:475-482, 2003. (Pubitemid 36520911)
7. Semik-Orzech A, Barczyk A, Wiaderkiewicz R, et al. IL-17 and RANTES levels in induced sputum of allergic rhinitis subjects after single nasal allergen challenge. Ann Allergy Asthma Immunol 103:418-424, 2009.
8. Pease JE. Asthma, allergy and chemokines. Curr Drug Targets 7:3-12, 2006.
9. Terada N, Hamano N, Kim WJ, et al. The kinetics of allergen-induced eotaxin level in nasal lavage fluid: Its key role in eosinophil recruitment in nasal mucosa. Am J Respir Crit Care Med 164:575-579, 2001. (Pubitemid 32801659)
10. Kobayashi Y. Neutrophil infiltration and chemokines. Crit Rev Immunol 26:307-316, 2006.
11. Lampinen M, Carlson M, Håkansson LD, et al. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 59:793-805, 2004. (Pubitemid 39005818)
12. Kuna P, Lazarovich M, and Kaplan AP. Chemokines in seasonal allergic rhinitis. J Allergy Clin Immunol 96:104-112, 1996. (Pubitemid 26045974)
13. Bachert C, van Kempen M, and Van Cauwenberge P. Regulation of proinflammatory cytokines in seasonal allergic rhinitis. Int Arch Allergy Immunol 118:375-379, 1999. (Pubitemid 29195578)
14. Benson M, Strannegård IL, Wennergren G, et al. Interleukin-5 and interleukin-8 in relation to eosinophils and neutrophils in nasal fluids from school children with seasonal allergic rhinitis. Pediatr Allergy Immunol 10:178-185, 1999. (Pubitemid 29505019)
15. Wagenmann M, Schumacher L, and Bachert C. The time course of the bilateral release of cytokines and mediators after unilateral nasal allergen challenge. Allergy 60:1132-1138, 2005. (Pubitemid 41153139)
16. KleinJan A, Dijkstra MD, Boks SS, et al. Increase in IL-8, IL-10, IL-13, and RANTES mRNA levels (in situ hybridization) in the nasal mucosa after nasal allergen provocation. J Allergy Clin Immunol 103:441-450, 1999. (Pubitemid 29136959)
17. Dreborg S, and Frew A. Position paper: Allergen standardization and skin tests. Allergy 47:48-82, 1993.
18. Riechelmann H, Bachert C, Goldschmidt O, et al. German Society for Allergology and Clinical Immunology (ENT Section); Working Team for Clinical Immunology. Application of the nasal provocation test on diseases of the upper airways. Position paper of the German Society for Allergology and Clinical Immunology (ENT Section) in cooperation with the Working Team for Clinical Immunology. Laryngorhinootologie 82:183-188, 2003.
19. Melillo G, Bonini S, Cocco G, et al. EAACI provocation tests with allergens. Report prepared by the European Academy of Allergology and Clinical Immunology Subcommittee on provocation tests with allergens. Allergy 52:1-35, 1997.
20. Greiff L, Pipkorn U, Alkner U, et al. The "nasal pool" device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions. Clin Exp Allergy 20:253-259, 1990.
21. Barczyk A, Pierzchala W, and Sozañska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med 97:726-733, 2003. (Pubitemid 36675678)
22. Chantry D, and Burgess LE. Chemokines in allergy. Curr Drug Targets Inflamm Allergy 1:109-116, 2002.
23. Kurt E, Aktas A, Gulbas Z, et al. The effects of natural pollen exposure on inflammatory cytokines and their relationship with nonspecific bronchial hyperresponsiveness in seasonal allergic rhinitis. Allergy Asthma Proc 31:126-131, 2010.
24. Zeibecoglou K, Ying S, Meng Q, et al. Expression of eotaxin in induced sputum of atopic and nonatopic asthmatics. Allergy 55:1042-1048, 2000.
25. Lamkhioued B, Renzi PM, Abi-Younes S, et al. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 159:4593-4601, 1997. (Pubitemid 127470622)
26. Lilly CM, Nakamura H, Belostotsky OI, et al. Eotaxin expression after segmental allergen challenge in subjects with atopic asthma. Am J Respir Crit Care Med 163:1669-1675, 2001. (Pubitemid 32578774)
27. Li J, Saito H, Crawford L, et al. Haemopoietic mechanisms in murine allergic upper and lower airway inflammation. Immunology 114:386-396, 2005. (Pubitemid 40314811)
28. Polosa R, Ciamarra I, Mangano G, et al. Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis. Eur Respir J 15:30-35, 2000. (Pubitemid 30068932)
29. Chakir J, Laviolette M, Turcotte H, et al. Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: Influence of natural allergen exposure. J Allergy Clin Immunol 106:904-910, 2000.
30. Persson CG, Erjefält JS, Andersson M, et al. Epithelium, microcirculation, and eosinophils - New aspects of the allergic airway in vivo. Allergy 52:241-255, 1997. (Pubitemid 27166226)
31. Hanazawa T, Antuni JD, Kharitonov SA, et al. Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis. J Allergy Clin Immunol 105:58-64, 2000. (Pubitemid 30059103)
32. Górski P, Wittczak T, Walusiak J, et al. Eotaxin but not MCP-3 induces eosinophil influx into nasal fluid in allergic patients. Allergy 57:519-528, 2000. (Pubitemid 34539125)
33. Minshall EM, Cameron L, Lavigne F, et al. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol 17:683-690, 1997. (Pubitemid 127348659)
34. Salib RJ, Lau LC, and Howarth PH. Nasal lavage fluid concentrations of eotaxin-1 (CCL11) in naturally occurring allergic rhinitis: Relationship to disease activity, nasal luminal eosinophil influx, and plasma protein exudation. Clin Exp Allergy 35:995-1002, 2005. (Pubitemid 41603132)
35. Greiff L, Petersen H, Mattsson E, et al. Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment. Clin Exp Allergy 31:1321-1327, 2000. (Pubitemid 34208973)
36. Erin EM, Leaker BR, Zacharasiewicz AS, et al. Single dose topical corticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challenge. Allergy 60:1524-1529, 2005. (Pubitemid 41654324)
37. Lopuhaä CE, Out TA, Jansen HM, et al. Allergen-induced bronchial inflammation in house dust mite-allergic patients with or without asthma. Clin Exp Allergy 32:1720-1727, 2002. (Pubitemid 35463856)
38. Bachert C, and Ganzer U. The role of pro-inflammatory cytokines in recruiting inflammatory cells in the nose. Laryngorhinootologie 72:585-589, 1993. (Pubitemid 24011362)
39. Gosset P, Tillie-Leblond I, and Malaquin F. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: Interleukin-8 is not the main chemotactic factor present in nasal lavages. Clin Exp Allergy 27:379-388, 1997. (Pubitemid 27183360)
40. Bocheńska-Marciniak M, Kupczyk M, Górski P, et al. The effect of recombinant interleukin-8 on eosinophils' and neutrophils' migration in vivo and in vitro. Allergy 58:795-801, 2003. (Pubitemid 36920472)
41. Ciprandi G, Cirillo I, Vizzaccaro A, et al. Nasal obstruction in patients with seasonal allergic rhinitis: Relationships between allergic inflammation and nasal airflow. Int Arch Allergy Immunol 134:34-40, 2004. (Pubitemid 38698097)
42. Nonaka M, Nonaka R, and Jordana M. GM-CSF, IL-8, IL-1R, TNF-alpha R, and HLA-DR in nasal epithelial cells in allergic rhinitis. Am J Respir Crit Care Med 153:1675-1681, 1996. (Pubitemid 26142837)
43. Proud D, Reynolds CJ, and Lichtenstein LM. Intranasal salmeterol inhibits allergen-induced vascular permeability but not mast cell activation or cellular infiltration. Clin Exp Allergy 28:868-875, 1998. (Pubitemid 28335565)